OVERVIEW

Continuing our dedication to providing a comprehensive and current update in the management of thyroid disease, USC presents the Peter A. Singer Thyroid Symposium in 2022.

This hybrid program, offered in person and over virtual platform, presents forward-looking perspectives on the most current state of thyroid medicine because clinical care of patients with thyroid disorders is a changing and increasingly complex practice, informed by evidenced-based management strategies.

For 2022, we highlights areas of advancement and current debate including new guideline recommendations for thyroid cancer, evaluating thyroiditis, autoimmunity's effect on pregnancy, use of molecular testing for thyroid nodules, new ablation techniques, and the management of hypoparathyroidism. Presentations combining evidence-based medicine and clinical experience, challenging cases, and panel discussions answering audience questions, will help inform clinical practice in an era of complex clinical problems.

TARGET AUDIENCE

This course is intended for endocrinologists, primary care providers, nurses and other allied health professionals. Head and Neck or Endocrine surgeons, and trainees seeking to enhance their understanding of thyroid diseases and treatment options in order to select optimal management for their patients.

LEARNING OBJECTIVES

By the end of the course, participants will be able to:

1. Discuss upcoming changes to American guidelines for the management of differentiated thyroid cancer.
2. Examine the data for the use of radio-frequency ablation for thyroid diagnoses.
3. Demonstrate the prognostic implications of molecular testing for thyroid nodules and cancer.
4. Identify causes and optimal treatments for different etiologies of thyroiditis.
5. Recognize the variety of causes for non-specific symptoms experienced by patients with thyroid disease.
6. Assess unique aspects in the oncogenesis and management of follicular and Hurthle cell thyroid cancer.
7. Appraise the relationship between thyroid autoimmunity and fertility.
8. Treat acute and chronic hypoparathyroidism.

ACCREDITATION

The Keck School of Medicine of the University of Southern California is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 5.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.